Abstract
The prevalence of Toxoplasma infection among patients with inflammatory bowel disease was studied. The Sabin-Feldman dye test was performed on 35 patients with Crohn's disease, 44 patients with ulcerative colitis, and 140 control patients. A higher incidence of positive reactions was found in Crohn's disease patients over the age of 40 (P<0.05). All other factors showed no significant differences among the three groups of patients. These factors include age younger than 40 years, sex, duration of disease, extent of disease, and type of treatment. It is concluded that there is no correlation between inflammatory bowel diseases and toxoplasmosis. Toxoplasma infection, however, should be considered in patients with Crohn's disease who are over 40 years old, and who present with nonspecific signs of intercurrent infection.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Auer IO, Ziemer E, Sommer H. Immune status in Crohn's disease: V. Decreasedin vitro natural killer cell activity in peripheral blood. Clin Exp Immunol 1980;42:41–9.
Smith PD. Infectious agents and inflammatory bowel disease (editorial). Gastroenterology 1983;85:475–6.
Gitnick GL, Rosen VJ, Arthur MH, Hertweck SA. Evidence for the isolation of a new virus from ulcerative colitis patients: comparison with virus derived from Crohn's disease. Dig Dis Sci 1979;24:609–19.
Swarbrick ET, Kingham JG, Price HL, Blackshaw AJ, Griffiths PD. Chlamydia, cytomegalovirus, and Yersinia in inflammatory bowel disease. Lancet 1979;2:11–2.
Burnham WR, Lennard-Jones JE, Stanford JL, Bird RG. Mycobacteria as a possible cause of inflammatory bowel disease. Lancet 1978;2:693–6.
Ruskin J, Remington JS. Toxoplasmosis in the compromised host. Ann Intern Med 1976;84:193–9.
Samuels BS, Rietschel RL. Polymyositis and toxoplasmosis. JAMA 1976;235:60–1.
Krick JA, Remington JS. Toxoplasmosis in the adult: an overview. N Engl J Med 1978;298:550–3.
Mitchell DN, Rees RJ. Agent transmissible from Crohn's disease tissue. Lancet 1970;2:168–71.
Bolton RP, Sherriff RJ, Read AE. Clostridium difficile associated with diarrhea: a role in inflammatory bowel disease? Lancet 1980;1:383–4.
Taylor-Robinson D, O'Morain CA, Thomas BJ, Levi, AJ. Low frequency of chlamydial antibodies in patients with Crohn's disease and ulcerative colitis. Lancet 1979;1:1162–3.
Fiocchi C, Youngman KR, Farmer RG. Immunoregulatory function of human intestinal mucosa lymphoid cells: evidence for enhanced suppressor cell activity in inflammatory bowel disease. Gut 1983;24:692–701.
Yuan SZ, Hanauer SB, Kluskens LF, Kraft SC. Circulating lymphocyte subpopulations in Crohn's disease. Gastroenterology 1983;85:1313–8.
Kirsner JB, Shorter RG. Recent developments in ‘non-specific’ inflammatory bowel disease. N Engl J Med 1982;306:775–85.
Kagen LJ, Kimball AC, Christian CL. Serologic evidence of toxoplasmosis among patients with polymyositis. Am J Med 1974;56:186–91.
Author information
Authors and Affiliations
About this article
Cite this article
Rattan, J., Hallak, A., Shvartzman, H. et al. Sabin-Feldman dye test in ulcerative colitis and Crohn's disease. Dis Colon Rectum 29, 402–404 (1986). https://doi.org/10.1007/BF02555059
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02555059